bioRxiv

Older minipigs modeling Huntington’s show more gene activity changes

Gene activity differed from unmodified minipigs for seven genes at age 4 and 3,324 at age 8.

Paper by Eva Kamenna, Kateryna Nemesh, Jakub Červenka, +12 more authorsJiri Klima · Institute of animal physiology and genetics
A large branching neuron with sparse dark markers sits among smaller neurons with dense or sparse markers, with two minipigs below.

Our read

Mechanisms
Studied:
Preprint: experiments in transgenic and wild-type minipigs, against minipigs aged 4 years
What changed:
Gene activity differences from wild-type minipigs increased from seven genes at 4 years to 3,324 at 8 years
The catch:
The model lacks somatic repeat expansion, a major driver of Huntington’s progression

Editor of record: Boris Djordjevic · AgingResearch.News

Follow @agingbrief

Genetically modified minipigs modeling Huntington’s disease were compared with unmodified minipigs at ages 4 and 8 in an animal experiment. The team measured gene activity and proteins in the putamen, a brain region that degenerates early in people with the disease. Gene activity differed for seven genes at 4 years and 3,324 at 8 years. At 8 years, gene activity and protein measurements pointed to similar changes in biological processes.

Markers of one type of nerve cell were reduced at 8 years in both analyses. The authors proposed that these reduced markers reflected a loss of nerve-cell identity rather than cell death. They suggested that the minipigs may model the disease’s slow early phase, when treatment is arguably most likely to help.

Why it matters

Huntington’s disease has no treatment that changes its course. Long-lived minipigs offer a way to follow the effects of a single gene-therapy dose for years.

Caveats

The minipig model lacks the expansion of repeated DNA within cells that is a major driver of progression in human Huntington’s disease. This preprint has not been peer-reviewed.

Comments

Be the first to comment.